Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry;Uso de antagonistas de los receptores de aldosterona tras el infarto de miocardio. Datos del registro REICIAM

Revista Espanola de Cardiologia

Volumn 64, Issue 11, 2011, Pages 981-987

  López De Sá, Esteban ^a   Martínez, Angel ^b   Anguita, Manuel ^c   Dobarro, David ^a   Jiménez Navarro, Manuel ^d  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Aldosterone antagonist; Heart failure; Myocardial infarction; Registry

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; COMPARATIVE STUDY; DRUG EFFICACY; GENDER; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; REVIEW; ST SEGMENT ELEVATION; SURVIVAL RATE; SURVIVAL TIME;

EID: 80055023652     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.06.013     Document Type: Article

References (23)

1. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321 (Pubitemid 36384098)
2. F. Van de Werf, J. Bax, A. Betriu, C. Blomstrom-Lundqvist, F. Crea, and V. Falk Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC). Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Versión corregida 13-9-2010 Rev Esp Cardiol 62 2009 293.e1 293.e47
3. E.M. Antman, M. Hand, P.W. Armstrong, E.R. Bates, L.A. Green, and L.K. Halasyamani 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Writing on Behalf of the 2004 Writing Committee Circulation 117 2008 296 329
4. S.G. Goodman, W. Huang, A.T. Yan, A. Budaj, B.M. Kennelly, and J.M. Gore The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes Am Heart J 158 2009 193-201.e1-5
5. P.A. Heidenreich, W.R. Lewis, K.A. LaBresh, L.H. Schwamm, and G.C. Fonarow Hospital performance recognition with the Get With The Guidelines Program and mortality for acute myocardial infarction and heart failure Am Heart J 158 2009 546 553
6. K.A. Eagle, E. Kline-Rogers, S.G. Goodman, E.P. Gurfinkel, A. Avezum, and M.D. Flather Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study Am J Med 117 2004 73 81 (Pubitemid 38953725)
7. A. Budaj, D. Brieger, P.G. Steg, S.G. Goodman, O.H. Dabbous, and K.A. Fox Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 146 2003 999 1006 (Pubitemid 37500773)
8. C. Doubeni, C. Bigelow, D. Lessard, F. Spencer, J. Yarzebski, and J. Gore Trends and outcomes associated with angiotensin-converting enzyme inhibitors Am J Med 119 2006 616.e9 616.e16
9. R.H. Mehta, M.T. Roe, A.Y. Chen, B.L. Lytle, C.V. Pollack Jr., and R.G. Brindis Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative Arch Intern Med 166 2006 2027 2034 (Pubitemid 44537186)
10. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-13.
11. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cuñat, and E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo, Registro Actualizado). Resultados globales Rev Esp Cardiol 61 2008 803 816
12. M. Hayashi, T. Tsutamoto, A. Wada, T. Tsutsui, C. Ishii, and K. Ohno Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction Circulation 107 2003 2559 2565 (Pubitemid 36628936)
13. A. Boccanelli, G.F. Mureddu, G. Cacciatore, F. Clemenza, A. Di Lenarda, and A. Gavazzi Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results Eur J Heart Fail 11 2009 68 76
14. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, and A. Perez The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
15. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
16. M. Jessup, W.T. Abraham, D.E. Casey, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 1977 2016
17. F. Zannad, J.J. McMurray, H. Krum, D.J. Van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
18. N.M. Albert, C.W. Yancy, L. Liang, X. Zhao, A.F. Hernandez, and E.D. Peterson Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
19. B. Maier, W. Thimme, R. Schoeller, A. Fried, S. Behrens, and H. Theres Improved therapy and outcome for patients with acute myocardial infarction - data of the Berlin Myocardial Infarction Registry from 1999 to 2004 Int J Cardiol 130 2008 211 219
20. R.J. Goldberg, F.A. Spencer, P.G. Steg, M. Flather, G. Montalescot, and E.P. Gurfinkel Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective Arch Intern Med 167 2007 1766 1773 (Pubitemid 47403065)
21. M. Moriel, D. Tzivoni, S. Behar, D. Zahger, H. Hod, and D. Hasdai Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes Int J Cardiol 131 2008 97 104
22. E.D. Peterson, B.R. Shah, L. Parsons, C.V. Pollack Jr., W.J. French, and J.G. Canto Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1045 1055
23. R. Carlhed, M. Bojestig, L. Wallentin, G. Lindstrom, A. Peterson, and C. Aberg Improved adherence to Swedish national guidelines for acute myocardial infarction: the Quality Improvement in Coronary Care (QUICC) study Am Heart J 152 2006 1175 1181 (Pubitemid 44854807)